Jpmorgan Chase & CO Senseonics Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 14,612 shares of SENS stock, worth $6,867. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,612
Previous 14,612
-0.0%
Holding current value
$6,867
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SENS
# of Institutions
149Shares Held
93.7MCall Options Held
564KPut Options Held
490K-
Vanguard Group Inc Valley Forge, PA33.5MShares$15.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA8.7MShares$4.09 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$3.91 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$2.64 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.73MShares$2.22 Million0.01% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $219M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...